Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences

Figure 4

The level of H19 transcripts in heterotopic subcutaneous tumors after injection of the ES-2 cells determined by RT-PCR. "M"100-bp molecular weight marker. Lines 1–4 – heterotopic subcutaneous tumors from different mice and Line 5 – negative control. The sizes of the PCR products are 300 bp and 213 bp for human H19 and Histone internal control respectively.

Back to article page